[{"PropertyPlantAndEquipmentNet_0_Q2_USD":2665000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":84823000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":5854000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1348225000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":3416000.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":1436000.0,"OperatingLeaseLiability_0_Q2_USD":15100000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":170192000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":169997000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ValuationAllowancesAndReservesChargedToCostAndExpense_2_Q2_USD":7782000.0,"InterestPaidNet_2_Q2_USD":723000.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":71450000.0,"InventoryFinishedGoods_0_Q2_USD":1351000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":7000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-42127000.0,"AssetsCurrent_0_Q2_USD":184198000.0,"LongTermDebt_0_Q2_USD":20000000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":44499000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":22378000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":445000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":129000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":9473000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":30873000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":1319000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":877000.0,"Assets_0_Q2_USD":201598000.0,"ShareBasedCompensation_2_Q2_USD":4945000.0,"OtherAssetsNoncurrent_0_Q2_USD":840000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-2030000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-13813000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":25690000.0,"ShortTermInvestments_0_Q2_USD":68564000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":5057000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":16000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":16419000.0,"InventoryRawMaterials_0_Q2_USD":5142000.0,"ValuationAllowancesAndReservesDeductions_2_Q2_USD":7526000.0,"EarningsPerShareBasic_1_Q2_USD":-0.08,"EarningsPerShareBasic_2_Q2_USD":0.15,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":8000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":11000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":170192000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":175912000.0,"AccountsReceivableNetCurrent_0_Q2_USD":17372000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":13895000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":801000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":-95000.0,"CommonStockValue_0_Q2_USD":171000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":497000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-1828000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":33633000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":16807000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":61316000.0,"CostsAndExpenses_2_Q2_USD":78577000.0,"CostsAndExpenses_1_Q2_USD":39314000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":153387000.0,"IncreaseDecreaseInInventories_2_Q2_USD":5158000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":25679000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-13821000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-970000.0,"LongTermLoansPayable_0_Q2_USD":19860000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q2_USD":2500000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":107284000.0,"EarningsPerShareDiluted_2_Q2_USD":0.15,"EarningsPerShareDiluted_1_Q2_USD":-0.08,"InvestmentsFairValueDisclosure_0_Q2_USD":94562000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":26480000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-14791000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2306000.0,"ValuationAllowancesAndReservesBalance_0_Q2_USD":6321000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":35261000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":169997000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":170192000.0,"InventoryWorkInProcess_0_Q2_USD":340000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":10485000.0,"LiabilitiesCurrent_0_Q2_USD":59544000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":54450000.0,"AccountsPayableCurrent_0_Q2_USD":1689000.0,"InterestExpense_2_Q2_USD":2244000.0,"InterestExpense_1_Q2_USD":1759000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":6606000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":12359000.0,"SubleaseIncome_2_Q2_USD":2634000.0,"SubleaseIncome_1_Q2_USD":1298000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q2_position":0.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":5915000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_2_Q2_USD":0.0,"OperatingLeasePayments_2_Q2_USD":5025000.0,"OperatingLeasePayments_1_Q2_USD":2529000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":10000000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":1399000.0,"LeaseCost_1_Q2_USD":1503000.0,"LeaseCost_2_Q2_USD":3072000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1280293000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":26266000.0,"OperatingIncomeLoss_2_Q2_USD":28707000.0,"OperatingIncomeLoss_1_Q2_USD":-13048000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":10381756.0,"InventoryNet_0_Q2_USD":6833000.0,"InvestmentIncomeInterest_2_Q2_USD":17000.0,"InvestmentIncomeInterest_1_Q2_USD":16000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":5813000.0,"PreferredStockValue_0_Q2_USD":null,"OperatingLeaseCost_2_Q2_USD":2680000.0,"OperatingLeaseCost_1_Q2_USD":1340000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":201598000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":7764000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-7439000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":7500000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2306000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":9221000.0,"ProfitLoss_2_Q2_USD":25679000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":48230000.0,"OtherLiabilitiesCurrent_0_Q2_USD":16234000.0,"StockholdersEquity_0_Q2_USD":68110000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":478000.0,"AccretionExpense_2_Q2_USD":1100000.0,"AccretionExpense_1_Q2_USD":1000000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":94554000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_2_Q2_USD":29801000.0,"VariableLeaseCost_2_Q2_USD":392000.0,"VariableLeaseCost_1_Q2_USD":163000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":4945000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":2795000.0,"Ticker":"RIGL","CIK":"1034842","name":"RIGEL PHARMACEUTICALS INC","OfficialName":"Rigel Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"488447519.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210803"}]